期刊文献+

心脏再同步化治疗中晚期心力衰竭的体会 被引量:5

下载PDF
导出
摘要 随着人口老龄化趋势的加剧,慢性心力衰竭(CHF)的发生率将不断增加并且成为一个严重的健康问题。CHF 5年存活率不足50%,为各种器质性心脏病的终末阶段。虽然药物治疗,包括血管紧张素转化酶抑制剂、β受体阻滞剂、利尿剂、洋地黄制剂,能改善患者的生存期和生活质量,但仍存在较高病死率。心力衰竭是一种渐进性疾病,预后差。
出处 《心肺血管病杂志》 CAS 2013年第3期366-367,共2页 Journal of Cardiovascular and Pulmonary Diseases
  • 相关文献

参考文献7

二级参考文献27

  • 1王方正,张澍,黄德嘉,华伟,孙宝贵,沈法荣,吴书林,王建安,方全,吴立群,王景峰,王冬梅,郭涛,陈新,中华医学会心电生理和起搏分会心脏再同步治疗专家工作组.心脏再同步治疗慢性心力衰竭的建议[J].中华心律失常学杂志,2006,10(2):90-102. 被引量:90
  • 2郭继鸿.深入认识心脏再同步化治疗心力衰竭的机制[J].中国心脏起搏与心电生理杂志,2006,20(4):283-284. 被引量:62
  • 3吴学思.2005年欧美慢性心力衰竭诊疗指南简介[J].心肺血管病杂志,2006,25(3):182-182. 被引量:9
  • 4刘兴斌.CRT降低心力衰竭死亡率但不改变猝死危险[J].心血管病学进展,2007,28(1):25-26. 被引量:4
  • 5蔡彬妮,黄卫斌.优化心脏再同步化治疗顽固性心力衰竭的策略[J].中国心脏起搏与心电生理杂志,2007,21(1):67-69. 被引量:12
  • 6Bristow MR,Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med ,2004,350:2140-2150.
  • 7Cleland JGF, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med, 2005. 352:1539-1549.
  • 8Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: exeeutive summary (update 2005):The Taqsk Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J,2005, 26:1115.
  • 9Bleeker GB,Schalij MJ, Molhoek SG, et al. Relationship between QRS duration and left ventricular dyssynchrony in patients with endstage heart failure. J Cardiovasc Electrophysiol, 2004,15 : 544.
  • 10Yu CM ,Lin H ,Zhang Q. High prevalence of left ventricular systolic and diastolic asynchrony in patients with congestive heart failure and normal QRS duration. Heart, 2003,89:54.

共引文献19

同被引文献74

  • 1潘娟.胺碘酮治疗心衰合并心律失常的疗效观察[J].医学信息(医学与计算机应用),2014,0(17):145-145. 被引量:1
  • 2宋涛,李臣文,赵文秀,葛志明.心肌缺血的能量代谢及代谢药物治疗[J].实用心脑肺血管病杂志,2006,14(10):766-768. 被引量:13
  • 3于雪梅,高暤.胺碘酮治疗老年人心衰并发室性心律失常34例临床分析[J].中国老年学杂志,2007,27(10):1001-1002. 被引量:4
  • 4黄峻.慢性心力衰竭临床研究的新趋势[J].中华心血管病杂志,2007,35(7):593-594. 被引量:44
  • 5陈瑾,杨新春,王树岩,朱建国,刘秀兰,吴雅峰,张麟.慢性心力衰竭患者心脏β_1受体自身抗体与心功能的相关性及临床意义[J].中华心血管病杂志,2007,35(7):599-602. 被引量:18
  • 6Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchroni- zation in chronic heart failure. N Engl J Med,2002,346:1845- 1853.
  • 7Dickstein K, Cohen-Solal A, Filippatos G, et ai. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Aeute and Chronic Heart Failure 2008 of the European Society of Cardi- ology. Developed in collaboration with the Heart Failure Associa- tion of the ESC (HFA) and endorsed by the European society of intensive care medicine (ESICM). Eur Heart J, 2008,29:2388- 2442.
  • 8Farwell D, Patel NR, Hall A, et ai. How many people with heart failure are appropriate for biventricular resynchronization? Eur Heart J, 2000, 21:1246-1250.
  • 9Cleland JG, Daubert JC, Erdmann E, et al. Longer-term effects of cardiac resynchronization therapy on mortality in heart failure ( the Cardiac Resynchronizatione Heart Failure [ CARE-HFI trial extension phase). Eur Heart J, 2006,27 : 1928-1932.
  • 10Linde C, Abraham WT, Gold MR, et al. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure pa- tients and in asymptomatic patients with left ventricular dysfunc- tion and previous heart failure symptoms. J Am CollCardiol, 2008,52 : 1834-1843.

引证文献5

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部